Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cytek Biosciences Lowers FY2025 Sales Guidance from $204.00M-$212.00M to $196.00M-$210.00M vs $204.43M Est

Author: Benzinga Newsdesk | May 08, 2025 03:43pm
Cytek Biosciences (NASDAQ:CTKB) lowers FY2025 sales outlook from $204.00 million-$212.00 million to $196.00 million-$210.00 million vs $204.43 million estimate.

Posted In: CTKB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist